The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $12.74

Today's change0.00 0.00%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $12.74

Today's change0.00 0.00%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc closed at (U.S.)$12.74.

Over the last five days, shares have gained 10.69%, but are down 17.59% for the last year to date. Shares have underperformed the S&P 500 by 28.98% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $12.74
  • High--
  • Low--
  • Bid / Ask(U.S.) $8.12 / (U.S.) $15.00
  • YTD % change-17.59%
  • Volume0
  • Average volume (10-day)2,267,701
  • Average volume (1-month)2,240,961
  • Average volume (3-month)2,636,701
  • 52-week range(U.S.) $11.00 to (U.S.) $19.68
  • Beta1.14
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward40.42×
  • Forward PEG1.63×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.47
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-6.12%

Allscripts Healthcare Solutions Inc has a net profit margin of -6.12%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue345351340351
Total other revenue--------
Total revenue345351340351
Gross profit131140138138
Total cost of revenue214211202213
Total operating expense364360352379
Selling / general / administrative978790109
Research & development46535248
Depreciation / amortization7888
Interest expense (income), net operating--------
Unusual expense (income)0201
Other operating expenses, total--------
Operating income-19-9-12-28
Interest income (expense), net non-operating-4-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax-26-16-19-35
Income after tax-26-18-21-21
Income tax, total022-14
Net income-26-18-21-21
Total adjustments to net income--------
Net income before extra. items-26-18-21-21
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-26-18-21-21
Inc. avail. to common incl. extra. items-26-18-21-21
Diluted net income-26-18-21-21
Dilution adjustment--000
Diluted weighted average shares180180179179
Diluted EPS excluding extraordinary itemsvalue per share-0.14-0.10-0.12-0.12
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.14-0.07-0.12-0.11